MARKET

CYAN

CYAN

Cyanotech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.570
+0.010
+0.39%
Closed 16:00 09/25 EDT
OPEN
2.490
PREV CLOSE
2.560
HIGH
2.570
LOW
2.490
VOLUME
1.30K
TURNOVER
--
52 WEEK HIGH
3.250
52 WEEK LOW
1.820
MARKET CAP
15.50M
P/E (TTM)
23.38
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Is Cyanotech (NASDAQ:CYAN) Set To Make A Turnaround?
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Simply Wall St. · 08/18 15:53
Cyanotech shares are trading lower after the company reported Q1 sales results down from last year.
Benzinga · 08/11 12:18
Cyanotech shares are trading lower after the company reported Q1 sales results down from last year.
Benzinga · 08/11 12:18
Cyanotech Q1 EPS $0.02 Up From $(0.02) YoY, Sales $7.35M Down From $8.07M YoY
Cyanotech (NASDAQ:CYAN) reported quarterly earnings of $0.02 per share. This is a 200 percent increase over losses of $(0.02) per share from the same period last year. The company reported $7.35 million in sales this
Benzinga · 08/11 12:12
Cyanotech Q1 EPS $0.02 Up From $(0.02) YoY, Sales $7.35M Down From $8.07M YoY
Cyanotech (NASDAQ:CYAN) reported quarterly earnings of $0.02 per share. This is a 200 percent increase over losses of $(0.02) per share from the same period last year. The company reported $7.35 million in sales this
Benzinga · 08/11 12:12
Cyanotech® Corporation Welcomes Charles J. Hartmann as Senior Sales and Marketing Director
Cyanotech® Corporation, (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced that Charles (C.J.) Hartmann has joined Cyanotech as the company’s new Senior Sales and Marketing Director effective
Business Wire · 07/23 13:00
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
Business Wire · 06/23 13:00
Cyanotech Q4 EPS $0.01 Up From $(0.25) YoY, Sales $8.63M Up From $6.06M YoY
Cyanotech (NASDAQ:CYAN) reported quarterly earnings of $0.01 per share. This is a 104 percent increase over losses of $(0.25) per share from the same period last year. The company reported $8.63 million in sales this
Benzinga · 06/23 12:26
More
Forecast
EPSBVPSCFPS
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CYAN. Analyze the recent business situations of Cyanotech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Institutional Holdings
Institutions: 19
Institutional Holdings: 731.67K
% Owned: 12.13%
Shares Outstanding: 6.03M
TypeInstitutionsShares
Increased
2
11.22K
New
5
-47.53K
Decreased
2
528
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.88%
Pharmaceuticals & Medical Research
+1.58%
Key Executives
Chairman/Independent Director
Michael Davis
Chief Executive Officer/Vice Chairman/Director
Gerald Cysewski
Chief Financial Officer/Vice President - Finance
Brian Orlopp
Vice President - Operations
Glenn Jensen
Vice President/General Manager
Matthew Custer
Vice President/Director of Human Resources/Secretary
Amy Nordin
Vice President
Jennifer Johansen
Director of Sales/Director of Marketing
Charles Hartmann
Independent Director
Nancy Katz
Independent Director
Walter Menzel
Independent Director
David Mulder
Independent Director
David Vied
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CYAN
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company's products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health. The Company cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The Company produces its algae in Hawaii and manufactures the finished products in Hawaii and California.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of CYANOTECH CORP stock information, including NASDAQ:CYAN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYAN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CYAN stock methods without spending real money on the virtual paper trading platform.